Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CELGENE

(CELG)
 SummaryChartsNewsCompany 
All news about CELGENE
2021Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential..
CI
2021CELGENE : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid«)
AQ
2021BESRA GOLD INC : Announces Lodgment of Replacement Prospectus & Adjournment of Note Holder..
NE
2021Celgene Corporation Will Grant Sun Pharmaceutical Industries Limited A License to Celge..
CI
2021CELGENE : Rocket docket pharma patent litigation taking off in Australia and other emergin..
AQ
2021DGAP-WPÜG : Tender Offer / Target company: ; Bidder: qqqqq
EQ
2021Cadila Healthcare Limited - Zydus Announces Settlement of Patent Litigation for Generic..
AQ
2021Leonteq becomes new issuer on BX Swiss – “deriBX”
TE
2021BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)
AQ
2021Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of ..
AQ
2021Celgene Corporation Issues Notice of Redemption of Notes
CI
2021Bristol-Myers Squibb Company and Celgene Corporation Announce Tender Offers for an Aggr..
CI
2021Ikena Oncology, Inc. announced that it has received $120 million in funding from a grou..
CI
2020AMGEN : Signs Licensing Agreement With Medicines Development for Global Health
MT
2020BRISTOL MYERS SQUIBB : Q3 Results Beat Estimates; Raises 2020 EPS Outlook
MT
More news
News in other languages on CELGENE
2021DGAP-WPÜG : Angebot zum Erwerb / Zielgesellschaft: ; Bieter: qqqqq
2021Leonteq wird neue Emittentin an der BX Swiss AG im Segment źderiBX╗
2021BX Swiss AG startet Handel in neuem Bondsegment
2020Amgen signe un accord de licence avec Medicines Development for Global Health (développ..
2020Les résultats du troisième trimestre de Bristol-Myers Squibb dépassent les estimations ..
More news
Analyst Recommendations on CELGENE
More recommendations
Chart CELGENE
Duration : Period :
Celgene Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Matt M. Roden President & Director
David V. Elkins CFO, Principal Accounting Officer & Executive VP
P. Joseph Campisi Director & Vice President
Katherine Reynolds Kelly Secretary & Director
Jeffrey Galik Treasurer